Skip to main content
. Author manuscript; available in PMC: 2024 Jan 1.
Published in final edited form as: Int Forum Allergy Rhinol. 2023 Mar 30;13(7):1061–1482. doi: 10.1002/alr.23079

TABLE X.B.

Evidence on adenotonsillectomy for pediatric OSA

Study Year LOE Study design Study groups Clinical endpoints Conclusion
Marcus et al.2054 2013 1b RCT Children with OSA followed up for 7-months:
1. T&A
2. Observation
PSG, behavior, quality of life, symptoms, neurobehavioral outcomes Improvement in both groups. Significantly greater improvement in the surgical group. No improvement in neurobehavioral outcomes in either group
Bhattacharjee et al.2116 2010 2b Observational cohort Children with OSA with before and after T&A PSG data Resolution of OSA Significant improvement in AHI but resolution in only 27%
Chinnadurai et al.2053 2017 1a SR of RCTs Children with OSA with T&A versus observation Improvement/resolution of OSA T&A compared to observation leads to short-term improvement in sleep outcomes in children with OSA
Venekamp et al.2115 2015 1a SR of RCTs Children with OSA with T&A vs. observation or CPAP Improvement/resolution of OSA T&A compared to observation or CPAP leads to benefits in PSG parameters quality of life, symptoms and behavior
Trosman et al.2120 2016 3a Observational cohort Children with mild OSA PSG T&A compared to observation leads to a significantly greater improvement in AHI especially in non-obese, non-syndromic children
Volsky et al.2121 2014 3b Observational cohort Children with mild OSA OSA-18 quality of life scores Quality of life significantly improves in children with mild OSA after T&A with less improvement with observation
Kheirandish-Gozal et al.2123 2014 3b Observational cohort Children with mild OSA treated with intranasal corticosteroid and oral montelukast PSG in subset; symptoms Beneficial effects in >80% of children
Liming et al.2125 2019 2b SR of observational cohorts Children with mild OSA treated with intranasal corticosteroid and oral montelukast PSG Treatment with montelukast and intranasal steroids or montelukast alone is beneficial for short-term management of mild pediatric OSA

Abbreviations: T&A, tonsillectomy with or without adenoidectomy; SR, systematic review.